Enhanced Equity Funds said Tuesday that it named Matthew Thompson as a vice president. Previously, Thompson worked at Riverside Partners where he served as a vice president. Based in New York City, EEF is a healthcare-focused private equity firm.
NEW YORK, Feb. 11, 2014 /PRNewswire/ — Enhanced Equity Funds (EEF), one of the preeminent healthcare focused private equity funds in the middle market, announced today the appointment of Matthew Thompson as a Vice President.
“Matthew brings extensive healthcare experience to Enhanced Equity,” said Malcolm Kostuchenko, Partner and Co-Founder of Enhanced. “We are excited for him to join Enhanced to help build the firm’s capabilities and expertise as well as open new avenues to deploy capital in exciting healthcare businesses.”
Mr. Thompson brings deep investing, operating and consulting experience to Enhanced Equity. Most recently, he was a Vice President at Riverside Partners, a Boston-based healthcare and technology focused investment firm. Prior to Riverside Partners, Mr. Thompson served in Corporate Development and Corporate Strategy at CVS Caremark, a Fortune 15 healthcare services business. In addition, he worked as a consultant at Monitor Group [Monitor Deloitte], a growth oriented consulting firm where he led projects across multiple healthcare verticals. He holds a B.S. from Georgetown University.
About Enhanced Equity Funds
Enhanced Equity Funds (“EEF”) is a private equity firm focused exclusively on investing in the healthcare industry. The firm’s collective industry expertise, relationships and investment strategy have facilitated the development of industry leading healthcare companies. EEF currently manages approximately $600 million of committed capital across two funds. For additional information on EEF, please visit www.enhancedequity.com.
Take your pick!
- Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
- VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.